Related Experiment Video
Updated: Jan 16, 2026
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Inflammatory bowel disease in paediatrics: Navigating the old challenges and emerging frontiers
Mohammed Al-Beltagi1,2, Nermin K Saeed3,4, Prabu Kumar Chokkalingam Mani5,6
1Department of Pediatrics, Faculty of Medicine, Tanta University, Tanta 31511, Algharbia, Egypt.
Insights
Pediatric inflammatory bowel disease (IBD) is rising globally, presenting unique challenges in children. Advances in precision medicine and microbiome therapies offer new hope for improved diagnosis and treatment.
Area of Science:
- Gastroenterology and Hepatology
- Pediatric Medicine
- Immunology
Background:
- Pediatric inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, shows increasing global prevalence.
- Children often exhibit more severe and extensive disease compared to adults, posing distinct clinical challenges.
- Environmental and genetic factors are key drivers of rising pediatric IBD rates, particularly in industrializing nations.
Purpose of the Study:
- To synthesize current knowledge on pediatric IBD, covering epidemiology, diagnosis, and management.
- To explore emerging frontiers in pediatric IBD care, including precision medicine and microbiome-targeted therapies.
- To highlight the unique challenges and evolving strategies for managing IBD in children.
Main Methods:
- Narrative synthesis of global and regional epidemiological data.
- Review of clinical classifications, diagnostic advancements, and management approaches.
- Emphasis on innovations in precision medicine, microbiome therapy, and multidisciplinary care.
Main Results:
- Pediatric IBD incidence is increasing worldwide, linked to environmental and genetic interactions.
- Novel diagnostic tools, age-specific treatments, biologics, and nutritional strategies are transforming care.
- Focus on very early-onset IBD, transition care, and policy adaptations reflects the complexity of pediatric IBD management.
Conclusions:
- The care landscape for pediatric IBD is rapidly evolving, requiring a child-centered approach.
- Addressing distinct pathophysiology and developmental impacts is crucial for effective management.
- Continued research into genetics, immune pathways, and the microbiome is vital for personalized therapies and better global outcomes.
Abstract:
Pediatric inflammatory bowel disease (IBD), encompassing Crohn's disease, ulcerative colitis, and IBD-unclassified, has become increasingly prevalent worldwide, including in previously low-incidence regions. Children often present with more extensive and aggressive disease, creating unique diagnostic and management challenges that differ significantly from adult-onset IBD. This review aims to synthesize current knowledge on pediatric IBD, highlighting historical challenges while exploring emerging frontiers in diagnosis, treatment, and long-term care strategies. A narrative synthesis of global and regional epidemiological data, clinical classifications, diagnostic advancements, management approaches, and psychosocial considerations was conducted, with a particular emphasis on innovations in precision medicine, microbiome-targeted therapy, and multidisciplinary care models. Pediatric IBD continues to rise globally, driven by environmental and genetic interactions, especially in rapidly industrializing regions. Novel diagnostic tools, age-specific treatment protocols, biologics, nutritional strategies, and psychosocial support are reshaping care. Emphasis on very early-onset IBD, transition care, and regional policy adaptations underscores the evolving complexity of managing pediatric IBD. The landscape of pediatric IBD care is rapidly evolving. Addressing the distinct pathophysiology, developmental impact, and healthcare challenges of pediatric patients requires an integrated, child-centered approach. Ongoing research into genetics, immune pathways, and the microbiome will be essential in tailoring precision therapies and improving outcomes globally.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: